Skip to content

Retrospective observational study of telemedicine in sublingual immunotherapy

Single center retrospective observational study of telemedicine in sublingual immunotherapy for cedar pollinosis and mite antigen induced allergic rhinitis - Single center retrospective observational study of telemedicine in sublingual immunotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000048427
Enrollment
160
Registered
2022-07-25
Start date
2022-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cedar pollinosis or mite antigen induced allergic rhinitis

Interventions

None listed

Sponsors

Yokohama City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Common to Both Group 1)Patients with cedar pollen allergy and/or mite allergic rhinitis whose target period includes the start of SLIT and 6 months after the start Telemedicine Group 1)Patients who have had at least one telemedicine within 6 months after the start of SLIT In-person care Group 1)Patients who have never had telemedicine and only have had in-person care within 6 months after the start of SLIT

Exclusion criteria

Exclusion criteria: Common to Both Group 1)Patients who reject to be included this study In-person care Group 1)Patients who start SLIT after the telemedicine system introduction

Design outcomes

Primary

MeasureTime frame
Drop-out rate at 6 months after the start of SLIT

Secondary

MeasureTime frame
Side effects Continuation rate for treatment Cost burden of patient Treatment effectivity

Countries

Japan

Contacts

Public ContactYumi Inoo

Yokohama City University School of Medicine Department of Medial Education

inoo.yum.dk@yokohama-cu.ac.jp045-787-2627

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026